WRBY - Warby Parker Inc.


25.89
1.030   3.978%

Share volume: 3,492,215
Last Updated: 04-20-2026
Medical Equipment/Ophthalmic Goods: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$24.86
1.03
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
35%
Profitability 39%
Dept financing 41%
Liquidity 35%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
11.74%
1 Month
7.07%
3 Months
-2.04%
6 Months
19.14%
1 Year
84.93%
2 Year
109.13%
Key data
Stock price
$25.89
P/E Ratio 
1,622.16
DAY RANGE
$24.50 - $26.13
EPS 
-$0.04
52 WEEK RANGE
$14.72 - $31.00
52 WEEK CHANGE
$80.04
MARKET CAP 
2.662 B
YIELD 
N/A
SHARES OUTSTANDING 
122.448 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,307,281
AVERAGE 30 VOLUME 
$2,258,860
Company detail
CEO: Neil Blumenthal
Region: US
Website: warbyparker.com
Employees: 3,030
IPO year: 2021
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. As of March 17, 2022, it had 160 retail stores in the United States and Canada.

Recent news